Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZQ6N
|
|||
| Drug Name |
CAR-T Cells targeting EGFRvIII
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 1 | [1] | |
| Company |
First Affiliated Hospital of Harbin Medical University
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Epidermal growth factor receptor variant III (EGFR vIII) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03267173) Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.